U.S. federal trademark · Serial No. 98055817 · Reg. No. 7645616
Administering discount group purchasing programs, namely, facilitating and negotiating gene therapy outcomes-based contracts with pharmaceutical manufacturers that require longitudinal patient tracking to assess therapy efficacy and durability, and value-based warranty payments to a risk pool to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or service
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.